Study Evaluating GAP-486 on Heart Rhythm in Patients With Coronary Artery Disease
Public ClinicalTrials.gov record NCT00137332. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study of the Effects GAP-486 on Ventricular Tachyarrhythmia Induction
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to learn the effects of a test drug on heart rhythms, which may become life-threatening if left untreated, and to provide data to see if the drug is well tolerated and safe.
Study identification
- NCT ID
- NCT00137332
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2005 (Type not available)
- Primary completion
- Not listed
- Completion
- Oct 2006 (Actual)
- Last update posted
- Dec 10, 2007
2005 – 2006
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Sacramento | California | 95819 | — |
| Not listed | San Francisco | California | 94143 | — |
| Not listed | Washington D.C. | District of Columbia | 20010 | — |
| Not listed | Orlando | Florida | 32803 | — |
| Not listed | Peoria | Illinois | 61606 | — |
| Not listed | Iowa City | Iowa | 52242 | — |
| Not listed | Worcester | Massachusetts | 01655 | — |
| Not listed | Ann Arbor | Michigan | 48109 | — |
| Not listed | Lansing | Michigan | 48910 | — |
| Not listed | Southfield | Michigan | 48075 | — |
| Not listed | Minneapolis | Minnesota | 55407 | — |
| Not listed | Newark | New Jersey | 07112 | — |
| Not listed | Winston-Salem | North Carolina | 27157 | — |
| Not listed | Cleveland | Ohio | 44109 | — |
| Not listed | Cleveland | Ohio | 44195 | — |
| Not listed | Hershey | Pennsylvania | 17033 | — |
| Not listed | Wynnewood | Pennsylvania | 19096 | — |
| Not listed | Falls Church | Virginia | 22042 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00137332, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 10, 2007 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00137332 live on ClinicalTrials.gov.